Stocks making the biggest moves premarket: Biogen, JetBlue, Didi and others

Check out the companies that are making news.

The Korea Economic Daily publication denied a report that it was in talks to buy Biogen and combine it with its biotech unit. On Wednesday, Biogen shares jumped 9.5%.

The airline has cut nearly 1,300 flights due to a surge in Covid-19 infections among its flight staff. The airline was down 1% before the market opened.

Didi Global reported a revenue decline and a $4.7 billion loss in the third quarter, and its shares fell in premarket trading. Didi has fallen in 12 of the past 15 trading days.

R.R. Donnelley received a non-binding acquisition proposal at $11 per share in cash. R.R. Donnelley has an agreement in place to be acquired by affiliates of private equity firm Chatham Asset Management. Donnelley shares were up 3.1% in premarket trading.

The shareholders of the blank check company approved the merger earlier this week, and the spin-off of Virgin Galactic will begin trading under the name Virgin Orbit on the OTC Bulletin Board.

The memory chip maker's stock lost 1.5% in the premarket after it warned that Covid-19 curbs in China's Xian tech hub would impact production. One of the world's biggest memory chip makers issued a similar warning.

A booster dose of the J&J Covid-19 vaccine was found to be 85% effective in preventing hospitalizations in a South African study.

Microstrategy's stock rose 1.1% in the premarket, tracking a rise in the price of the virtual currency. Microstrategy has a lot of holdings in the digital currency.